FB VISION is a pioneering ophthalmic company established in 2015 and is a part of the esteemed "FB international scientific research Group." The company's primary focus lies in researching, developing, and producing high-quality products geared towards preventing and treating eye-related pathologies, with a strong emphasis on therapeutic areas such as GLAUCOMA, OCULAR SURFACE, NEUROPROTECTION, and OCULAR SURGERY.
The FB in the company's title denotes the initials of its Chairman and Founder, Francesco Bellini, who is a distinguished Italian naturalized Canadian scientist-entrepreneur renowned in the bio-pharmaceutical industry. The company prides itself on its exceptional team of professionals with extensive experience in the ophthalmic sector and aspires to establish itself as a leading entity for both ophthalmologists and patients.
Operating within the Medical Devices and Pharmaceutical industries, FB VISION is driven by the slogan, "Our story, your eyes," exemplifying its commitment to impacting the lives of individuals through innovative eye care solutions.